GRTX
Goldman Sachs’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,974
| Closed | -$2.1K | – | 4970 |
|
|
2023
Q3 | $2.1K | Sell |
11,974
-19,828
| -62% | -$3.47K | ﹤0.01% | 4685 |
|
|
2023
Q2 | $99.2K | Buy |
31,802
+20,487
| +181% | +$63.9K | ﹤0.01% | 4567 |
|
|
2023
Q1 | $29K | Sell |
11,315
-48
| -0.4% | -$123 | ﹤0.01% | 4839 |
|
|
2022
Q4 | $16.9K | Sell |
11,363
-92
| -0.8% | -$137 | ﹤0.01% | 4909 |
|
|
2022
Q3 | $20K | Sell |
11,455
-182
| -2% | -$318 | ﹤0.01% | 5172 |
|
|
2022
Q2 | $15K | Sell |
11,637
-4,201
| -27% | -$5.42K | ﹤0.01% | 5468 |
|
|
2022
Q1 | $38K | Sell |
15,838
-6,311
| -28% | -$15.1K | ﹤0.01% | 5515 |
|
|
2021
Q4 | $102K | Buy |
22,149
+10,428
| +89% | +$48K | ﹤0.01% | 5212 |
|
|
2021
Q3 | $95K | Buy |
11,721
+1
| +0% | +$8 | ﹤0.01% | 5068 |
|
|
2021
Q2 | $115K | Sell |
11,720
-1,085
| -8% | -$10.6K | ﹤0.01% | 5084 |
|
|
2021
Q1 | $113K | Sell |
12,805
-3,584
| -22% | -$31.6K | ﹤0.01% | 5002 |
|
|
2020
Q4 | $168K | Sell |
16,389
-4,717
| -22% | -$48.4K | ﹤0.01% | 4329 |
|
|
2020
Q3 | $191K | Buy |
+21,106
| New | +$191K | ﹤0.01% | 4078 |
|